Replacing visual acuity screenings for new Medicare enrollees with coverage of a dilated eye exam for healthy patients entering the government insurance program for the elderly "would be highly cost-effective," suggests a ...
Jan 9, 2012
0
0
Richard Carpenter, 75, was going through the mail one day last year when he saw a postcard from UCI seeking participants for a study on whether exercise can help with age-related memory loss.
Jun 4, 2019
0
14
(HealthDay)—Tamiflu (oseltamivir) can now be given to children as young as 2 weeks old under an expanded approval announced Friday by the U.S. Food and Drug Administration.
Dec 22, 2012
2
0
Vending machines dispensing self-test kits for sexually transmitted infections (STIs) are an effective and acceptable means of reaching people who rarely or never get tested, find the results of a year-long pilot, published ...
Feb 2, 2024
0
20
Scientists have found that low-level exposure to organophosphates (OPs) produces lasting decrements in neurological and cognitive function. Memory and information processing speed are affected to a greater degree than other ...
Dec 2, 2012
0
0
Rice University bioengineering students have modified a child-size training mannequin to give medical students hands-on pediatric experience so that real patients can be spared further stress and pain.
May 16, 2011
0
0
Common causes for stillbirth include obstetric complications and placental abnormalities, while factors that could be known at the start of pregnancy, such as previous stillbirth or pregnancy loss, were associated with an ...
Dec 13, 2011
0
0
Treatment guidelines for hypertension in pregnancy suggest that more women should be on medication to control their blood pressure. However, new research led by the Centre for Health Evaluation and Outcome Sciences (CHÉOS) ...
May 11, 2020
0
34
In a recently published study, Vera Bittner, M.D., professor in the University of Alabama at Birmingham Division of Cardiovascular Disease, and colleagues have demonstrated that weight cycling is associated with a lower rate ...
Feb 15, 2019
0
7
The U.S. Food and Drug Administration approved Tyruko (natalizumab-sztn), the first biosimilar to Tysabri (natalizumab) injection, for the treatment of relapsing forms of multiple sclerosis, the agency announced Thursday.
Aug 27, 2023
0
2
